The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft ModelsWenyu Hu, Nanlin Li|Breast Cancer Targets and Therapy|2023Cited by 4